4VV Stock Overview
Acquires, owns, and operates in cannabis business in medical and recreational cannabis sectors in California, the United States.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Juva Life Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.021 |
| 52 Week High | US$0.052 |
| 52 Week Low | US$0.01 |
| Beta | 0.72 |
| 11 Month Change | -41.67% |
| 3 Month Change | -16.00% |
| 1 Year Change | -50.59% |
| 33 Year Change | -93.29% |
| 5 Year Change | n/a |
| Change since IPO | -96.52% |
Recent News & Updates
Recent updates
Shareholder Returns
| 4VV | DE Pharmaceuticals | DE Market | |
|---|---|---|---|
| 7D | -25.0% | -5.6% | -0.1% |
| 1Y | -50.6% | -18.5% | 2.3% |
Return vs Industry: 4VV underperformed the German Pharmaceuticals industry which returned -18.5% over the past year.
Return vs Market: 4VV underperformed the German Market which returned 2.3% over the past year.
Price Volatility
| 4VV volatility | |
|---|---|
| 4VV Average Weekly Movement | 59.9% |
| Pharmaceuticals Industry Average Movement | 5.7% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.3% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: 4VV's share price has been volatile over the past 3 months.
Volatility Over Time: 4VV's weekly volatility has increased from 52% to 60% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2018 | n/a | Doug Chloupek | juvalife.com |
Juva Life Inc. acquires, owns, and operates in cannabis business in medical and recreational cannabis sectors in California, the United States. The company operates through two segments, The Resale of Merchandise and Cannabis-Derived Products and Cultivation and Sale of Trim and Flowers. Juva Life Inc. was founded in 2018 and is based in Vancouver, Canada.
Juva Life Inc. Fundamentals Summary
| 4VV fundamental statistics | |
|---|---|
| Market cap | €1.68m |
| Earnings (TTM) | -€6.35m |
| Revenue (TTM) | €7.39m |
0.0x
P/S Ratio0.0x
P/E RatioIs 4VV overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4VV income statement (TTM) | |
|---|---|
| Revenue | US$7.93m |
| Cost of Revenue | US$6.53m |
| Gross Profit | US$1.40m |
| Other Expenses | US$8.22m |
| Earnings | -US$6.81m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.042 |
| Gross Margin | 17.69% |
| Net Profit Margin | -85.90% |
| Debt/Equity Ratio | 222.3% |
How did 4VV perform over the long term?
See historical performance and comparison